Navigation Links
The race toward an interferon free world: The current field of Hepatitis C Virus treatment research, including recent financial deals
Date:4/26/2013

NEW YORK, April 26, 2013 /PRNewswire/ -- Citeline®, an Informa business unit, and the world's leading research authority on pharmaceutical clinical trials has just published an exclusive whitepaper examining the current progress towards a remarkable improvement in the medical treatment for HCV.

(Logo: http://photos.prnewswire.com/prnh/20120917/NE75453LOGO

With news of the impending breakthrough in HCV treatment, Citeline reviews the current landscape of clinical trials and drugs in this competitive space as well as the recent history of HCV-related financial deals.  In addition the whitepaper takes a look at the timing of current Phase III trials evaluating all oral regimens to determine how long Gilead may be the sole player in this space.  

Based on information in Citeline's clinical trial intelligence tool, Trialtrove®, 83% of the 200 planned and ongoing Phase I-III clinical trials for pipeline HCV drugs (excluding vaccines) are being conducted by 10 companies; these 10 companies, including Bristol-Myers Squibb, Gilead, Merck and AbbVie, among others, are the focus of this report. Gilead leads in the number of Phase II trials and is conducting over twice as many as the next most active Phase II sponsor, Bristol-Myers Squibb.

According to Doro Shin , MPH, Citeline's Senior Analyst, Infectious & Genitourinary Diseases, "Gilead's lead in direct acting antiviral (DAA) agents for the treatment of HCV could lead to a shorter, oral, and interferon free treatment of the disease, with a dramatic reduction in unwanted side effects. This is truly a new era in HCV treatment. "

Moreover, in reviewing deals over the last five years we discovered between March 2008 and March 2013, there were a total of 18 HCV specific industry partnerships. In both years partnerships comprised of r
'/>"/>

SOURCE Citeline
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
2. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
3. Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
4. Medical Marijuana Inc. and Canipa Holdings Drive Dixie X and CanChew Gum Toward EU Marketing Approval And Clinical Development
5. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
6. Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region
7. The Shift from Treatment to Prevention: A Drive towards Cutting Healthcare Costs
8. Emerging Growth Pharmaceutical Company Creates Gravitational Pull Towards Their Products
9. In Vitro Diagnostics Markets Grow at Double the Pace of Pharma Markets in Shift toward Globalization
10. Optimism of Cannabis Patients Creates More Demand for Phytiva Brand of Cannabinoid Solutions as Illinois and New Hampshire Take Key Legislative Steps Toward Legalization of Medical Cannabis
11. Novartis signs on to support Malaria No Mores Power of One campaign to stride towards a future without malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... SANTA ANA, Calif. , March 2, 2015 ... premier supplier of child-resistant packaging solutions for ... Co-Founder, Nicholas Kovacevich , has been nominated ... The Excellence in Entrepreneurship Award is ... entrepreneurial spirit – individuals who, by their creativity ...
(Date:3/2/2015)... NEW YORK , March 2, 2015 /PRNewswire/ ... LLC is investigating potential claims on behalf of ... ("Vitae Pharmaceuticals" or the "Company") (NasdaqGM: VTAE -News).  ... Bronstein or his investor relations coordinator ... 212-697-6484. The investigation concerns whether Vitae ...
(Date:3/2/2015)... March 2, 2015  CANTEL MEDICAL CORP. (NYSE: ... Krakauer , CEO, will be presenting at the Sidoti ... The formal presentation is scheduled for 2:00 PM ET ... Hotel, New York . In addition, ... Development, will be available for separate one-on-one meetings during ...
Breaking Medicine Technology:Kush Bottles CEO, Nicholas Kovacevich, Nominated for 2015 "Excellence in Entrepreneurship Award" 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vitae Pharmaceuticals, Inc. 2
... Pharmaceuticals, Inc. (Nasdaq: AUXL ) today announced ... 2011 Healthcare Conference during September 7-9, 2011 at the ... Financial Officer, is scheduled to present an overview of ... ET on Wednesday, September 7, 2011.   ...
... 2011 Wendy R. Fleishman ... Bernstein, LLP announced that Tiffany Littles, 33, of Jacksonville, Florida, ... for severe and lasting injuries caused by Bayer,s birth control ... prescription drug sold without adequate warnings about the risk of ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference 2Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference 3Florida Woman Charges Life-Threatening Blood Clot Caused by Yaz Birth Control Drug According to Lieff Cabraser Heimann & Bernstein, LLP 2
(Date:3/2/2015)... (PRWEB) March 02, 2015 Doctors in ... be a better predictor of outcomes for people with ... read details of the new study on the ... at the University of Eastern Piedmont followed the cases ... pleurodesis treatment for excess lung fluid. , “Persistent ...
(Date:3/2/2015)... Angeles, CA (PRWEB) March 02, 2015 ... offering gum reshaping procedures. Gum reshaping can involve one or ... or to regenerate lost gum tissue for a more even ... dark gum line treatment that can permanently lighten ... his total smile approach, which involves a personalized treatment plan ...
(Date:3/2/2015)... 02, 2015 After a rigorous evaluation ... service, pricing and long-term strategy, Blood Centers of America ... choice for member centers’ testing needs. , BCA, which ... more than 30 percent of the U.S. blood supply, ... “BCA is committed to drive cost savings to members,” ...
(Date:3/2/2015)... 02, 2015 New York singer/songwriter ... be delivering a plenary address entitled Finding the ... Art of Healing and Recovery at this year’s ... Healthcare Executive Summit (BHES).     , With more than ... have been recorded by some of the biggest ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Over the ... acquisitions among leading vendors seeking to expand their geographic ... market is expected to reach $6.2 billion by 2019 ... North America including the U.S. and Canada and a ... devices. However developing regions such as Asia-Pacific including China ...
Breaking Medicine News(10 mins):Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3
... Steven Reinberg HealthDay Reporter , THURSDAY, April 12 ... partners are having babies than ever before, a new government ... 2010 were to such couples -- a threefold increase from ... Prevention found. "It,s thought that in births outside of ...
... In a study published in Nutrition Research , ... consumption with nutrient intake, diet quality and the prevalence ... in both children and adults. Consumers of OOHN, including ... pine nuts, pistachios and walnuts), had higher intakes of ...
... April 11, 2012 -- In a scientific paper ... researchers from SomaLogic and the University of Washington in ... assay technology to tissue samples. Working with both tumor ... lung cancer (NSCLC), they identified significant expression changes in ...
... , WEDNESDAY, April 11 (HealthDay News) -- The spouses ... and stroke, a new study suggests. Researchers said the ... health of caregivers. Using the national Swedish cancer registry ... heart disease and stroke increased by 13 to 29 percent ...
... , WEDNESDAY, April 11 (HealthDay News) -- Treatment-related ... their therapy has been completed, a new study says. ... and found that more than 60 percent of them ... years after their diagnosis, and 30 percent had at ...
... , WEDNESDAY, April 11 (HealthDay News) -- ... people in the United States who lived in state-regulated ... federal report. People who live in residential care ... supportive services because they can,t live independently but generally ...
Cached Medicine News:Health News:More Unmarried Couples Having Babies: CDC 2Health News:Out-of-hand tree nut consumption associated with better diet quality in children and adults 2Health News:SomaLogic publishes proteomic biomarker analysis of lung cancer tissue samples 2Health News:Breast Cancer Treatment Side Effects May Last for Years 2